Introduction

Associate Editor Dr. Mario Kuzola discusses the review series on classical myeloproliford of neoplasms. Until the end of the 90s, these were neglected disorders whose pathogenesis was unknown. The turning point was in 2004, when William V. van Chonke identified the gain of function V617F mutation in the gene JAC2.